|
⚲
|
| Keyboard |
| Rocca Fortunato R
✚
|
|
|---|---|
| CIK # | 0001492734 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001492734] | |
| 4 | [0001492734] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rocca Fortunato R | |
| Exagen Inc | |
| Interpace Biosciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Exagen Inc XGN
Common Stock
|
2022-03-01 | Tax withheld | 4,322 | $7.12 | 30,773 |
|
Exagen Inc XGN
Common Stock
|
2022-02-04 | Grant | 75,000 | $0.00 | |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2021-02-23 | Grant | 40,000 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2021-02-23 | Grant | 50,000 | $0.00 | |
|
Interpace Biosciences Inc IDXG
Stock Option (right to buy) · derivative
|
2020-07-09 | Grant | 28,000 | $0.00 | |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2020-01-09 | Grant | 155,000 | $0.00 | |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2019-09-18 | Grant | 138,659 | $0.00 |